Biotech / PharmaOR
Cascade Prodrug
Biotech / Pharma
, OR
Cascade Prodrug is an oncology-focused biotechnology company developing a novel class of hypoxia-activated prodrug therapies that target diseases rooted in oxygen deprivation, including solid tumors and wet AMD. Its lead program, CPD100, is designed to selectively activate in hypoxic tissue. The company is led by seasoned pharmaceutical and biotech executives.
Founded
Region
OR
Investors
People